HFE Mutation and Dietary Iron Content Interact to Increase Ischemia/Reperfusion Injury of the Heart in Mice

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Circulation Research

• Publication date

  2003-06-13

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1161/01.RES.0000076890.59807.23PMID 12750309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase

  2004cited by this paper
• Mechanisms of iron accumulation in hereditary hemochromatosis.

  2002cited by this paper
• Transgene overexpression of αB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion

  2001cited by this paper
• HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.

  2001cited by this paper
• Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion.

  2001cited by this paper
• BROADSHEET NUMBER 54: HEREDITARY HEMOCHROMATOSIS

  2000cited by this paper
• Of metals, mice, and men: what animal models can teach us about body iron loading.

  2000cited by this paper
• Hemochromatosis Heterozygotes May Constitute a Radiation-Sensitive Subpopulation

  2000cited by this paper
• Hemochromatosis heterozygotes may constitute a radiation-sensitive subpopulation.

  2000cited by this paper
• Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload.

  1999cited by this paper
• HFE gene knockout produces mouse model of hereditary hemochromatosis.

  1998cited by this paper
• Hereditary hemochromatosis: gene discovery and its implications for population-based screening.

  1998cited by this paper
• Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis.

  1998cited by this paper
• Apoptosis in the failing heart.

  1998cited by this paper
• Apoptosis in the failing human heart.

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.

  1996cited by this paper
• Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.

  1996cited by this paper
• Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress.

  1995cited by this paper
• Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde.

  1995cited by this paper
• Antioxidant status and lipid peroxidation in hereditary haemochromatosis.

  1994cited by this paper
• Body iron stores and risk of cancer

  1994cited by this paper
• Antioxidant effectiveness in ischemia-reperfusion tissue injury.

  1994cited by this paper
• Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: an ESR spin-trapping investigation.

  1991cited by this paper
• Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning".

  1990cited by this paper
• Body iron stores and the risk of cancer.

  1988cited by this paper
• Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.

  1987cited by this paper
• Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis.

  1985cited by this paper
• Oxygen toxicity, oxygen radicals, transition metals and disease.

  1984cited by this paper
• Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy.

  1980cited by this paper

• SS-31@Fer-1 Alleviates ferroptosis in hypoxia/reoxygenation cardiomyocytes via mitochondrial targeting.

  2025cites this paper
• Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy

  2023cites this paper
• Hereditary hemochromatosis with homozygous C282Y HFE mutation: possible clinical model to assess effects of elevated reactive oxygen species on the development of cardiovascular disease

  2023cites this paper
• Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases

  2022cites this paper
• Role of Iron-Related Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases

  2022cites this paper
• Iron in Cardiovascular Disease: Challenges and Potentials

  2021cites this paper
• Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis

  2020cites this paper
• Icariin protects cardiomyocytes against ischaemia/reperfusion injury by attenuating sirtuin 1‐dependent mitochondrial oxidative damage

  2018cites this paper
• 23 Are Hemochromatosis Mutations Protective Against Iron-Mediated Atherogenesis ?

  2017cites this paper
• Interleukin-6 and hepcidin expression changes in cardiac tissue of long-term trained and untrained rats after exhaustive exercise

  2017cites this paper
• A comparative study of myocardial molecular phenotypes of two tfr2β null mice: role in ischemia/reperfusion.

  2015cites this paper
• Status of Superoxide Dismutase in Transfusion Dependent Thalassaemia

  2015cites this paper
• Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytes

  2014cites this paper
• Epidemiological associations between iron and cardiovascular disease and diabetes

  2014cites this paper
• Absorption of Manganese and Iron in a Mouse Model of Hemochromatosis

  2013cites this paper
• Decreased Hepcidin-25 Level as a Predictor of Poor Prognosis in Acute Coronary Syndrome Patients

  2013cites this paper
• Association Animal Models of Heart Failure : A Scientific Statement From the American Heart

  2012cites this paper
• Hepatic Pathobiology of Iron Overload

  2012cites this paper
• Animal models of heart failure: a scientific statement from the American Heart Association.

  2012cites this paper
• Oxygen Sensing, Cardiac Ischemia, HIF-1α and Some Emerging Concepts

  2010cites this paper
• The iron-regulatory peptide hepcidin is upregulated in the ischemic and in the remote myocardium after myocardial infarction.

  2010cites this paper
• Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment.

  2010cites this paper
• Expression of the peptide hormone hepcidin increases in cardiomyocytes under myocarditis and myocardial infarction.

  2010cites this paper
• Microarray studies of genome-wide changes in brain and heart gene expression in mouse models of iron overload

  2010cites this paper
• Serum hepcidin-20 is elevated during the acute phase of myocardial infarction.

  2009cites this paper
• The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.

  2009cites this paper
• Basic Mechanisms Mediating Cardiomyopathy and Heart Failure in Aging

  2009cites this paper
• Do Hemochromatosis Mutations Protect Against Iron-Mediated Atherogenesis?

  2009cites this paper
• Increased expression of the F(1)F(o) ATP synthase in response to iron in heart mitochondria.

  2008cites this paper
• Chapter 7 Thioredoxin Signaling in the Ischemic Heart

  2008cites this paper
• Cardiomyopathy and Heart Failure in Aging

  2008cites this paper
• Thioredoxin Signaling in the Ischemic Heart

  2008cites this paper
• Short term protective effects of iron in a murine model of ischemia/reperfusion

  2007cites this paper
• The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation.

  2007cites this paper
• VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium.

  2007cites this paper
• induced arrhythmogenic activity and contractile dysfunction

  2006cites this paper
• Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy

  2006cites this paper
• Myocardial Iron Metabolism in the Regulation of Cardiovascular Diseases in Rats

  2006cites this paper
• Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats

  2006cites this paper
• Antioxidants and Chronic Vascular Disease: Animal Studies

  2006cites this paper
• Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile Dysfunction

  2006cites this paper
• Molecular and clinical aspects of iron homeostasis: from anemia to hemochromatosis

  2006cites this paper
• Combination of Iron Overload Plus Ethanol and Ischemia Alone Give Rise to the Same Endogenous Free Iron Pool

  2005cites this paper
• Iron in skin of mice with three etiologies of systemic iron overload.

  2005cites this paper
• Iron and oxidative injury-- a commentary on "Fatty acid-mediated iron translocation: a synergistic mechanism of oxidative injury" by D. Yao et al.

  2005cites this paper
• In vivo protective effects of urocortin on ischemia-reperfusion injury in rat heart via free radical mechanisms.

  2005cites this paper
• Redox regulation of angiotensin II siganling in the heart

  2004cites this paper
• Iron, free radicals, and oxidative injury.

  2004cites this paper
• The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis

  2004cites this paper
• Serum Hepcidin Level after AMI

  2003cites this paper